MGI Pharma INC
SEC CIK 702131 · MOGN · last insider filing 2008-01-30
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Sharrock David B | Director | filed 2006–2008 |
| Mitchell Dean J | Director | filed 2006–2008 |
| Mehrer Edward W | Director | filed 2006–2008 |
| Moulder Leon O JR | Director · President & CEO | filed 2006–2008 |
| Ferrara Andrew J | Director | filed 2006–2008 |
| Miller Hugh E | Director | filed 2006–2008 |
| Weaver Arthur L | Director | filed 2006–2008 |
| Tuttle Waneta C | Director | filed 2006–2008 |
| Armitage James O | Director | filed 2006–2008 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Loukas Eric P | VP, General Cousel &Secretary | filed 2006–2008 |
| Spengler William | Sr. VP, CFO | filed 2006–2008 |
| Rodgers Richard J | VP & Controller | filed 2006–2008 |
| Hedley Mary Lynne | Sr. VP & Chief Scientific Off | filed 2006–2008 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.